P-141

PT-141 Research Peptide

PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist supplied exclusively for laboratory, analytical and scientific research purposes.

PT-141 is of research interest because of its interactions with melanocortin receptors and associated signalling pathways. It has been investigated in pharmacological and physiological research examining melanocortin receptor activity and central nervous system signalling.

Areas of Research Interest

PT-141 is studied in research settings involving:

• Melanocortin receptor activity

• MC3R and MC4R-associated signalling

• Receptor-binding mechanisms

• Central nervous system signalling pathways

• Melanocortin-system research

• Neuroendocrine signalling

• Structure–activity relationships

• Pharmacological peptide research

PT-141 may be of interest to researchers investigating melanocortin receptor pathways and peptide-receptor interactions under appropriately controlled experimental conditions.

Research Use Only

For laboratory research purposes only. Not for human or veterinary use.

This product is not a medicine, food or dietary supplement and is not intended for personal consumption, injection or administration.

It is not intended to diagnose, treat, cure or prevent any disease or medical condition. No claims are made regarding safety or efficacy for human use.

Purchasers are responsible for ensuring appropriate storage, handling and use in accordance with applicable laws and laboratory procedures.